Integrating Analytical Procedures in Routine Practices of Centralized Antiblastic Compounding Units for Valorization of Residual Compounded Drugs
Background/Objectives: Although extemporaneous formulations of anticancer drug products for personalized therapy are produced according to Good Hospital Pharmacy Manufacturing Practice, the lack of knowledge about drug stability under clinical conditions limits the second-time use of these highly co...
Saved in:
Main Authors: | Rita Patrizia Aquino, Giovanni Falcone, Paola Russo, Fabrizio Dal Piaz, Giulia Auriemma, Ferdinando Maria de Francesco, Stefania Cascone, Eduardo Nava, Pasquale Del Gaudio |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-01-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/1/101 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mechanistic Insights into the Anticancer Potential of Methoxyflavones Analogs: A Review
by: Mohammad Aidiel, et al.
Published: (2025-01-01) -
Potential Medicinal Fungi from Freshwater Environments as Resources of Bioactive Compounds
by: Ilenia Cicero, et al.
Published: (2025-01-01) -
Adenine, a key player in biology and medicinal chemistry
by: Fillion, Alexandra, et al.
Published: (2024-04-01) -
Anticancer activity of Ilex khasiana, a rare and endemic species of holly in Northeast India, against murine lymphoma
by: Charles Lalnunfela, et al.
Published: (2025-01-01) -
Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases
by: Dan Chen, et al.
Published: (2025-01-01)